Exuviance Clarifying Facial Cleanser Duo

Address oily and acne-prone skin with this soap-free cleanser, formulated with Salicylic and Mandelic Acids, specifically for problematic skin.
Special Savings: A $72 value for only $64!
  • Salicylic and Mandelic Acids exfoliate pores to clarify and help control oiliness
  • Removes makeup, dirt, and excess oil
  • Helps reduce problematic bacteria
  • Ideal for oily/acne-prone skin
Item #: F20009XDUOB
Exuviance Clarifying Facial Cleanser Duo
Item #: F20009XDUOB
$64.00
In Stock

Qty

Take a stand against oily and acne-prone skin with this soap-free cleanser, specifically created for problematic skin. This foaming formula dissolves impurities such as makeup, dirt and excess oil and reduces bacteria that can trigger a breakout. A blend of Salicylic and Mandelic Acids exfoliates pores to clarify and help control oiliness, while the antiaging Polyhydroxy Acid formulation helps maintain skin’s natural pH balance. Light conditioners including botanical Tea Tree Oil soothe and improve skin texture. Skin is thoroughly clean and soft. Dermatologist tested. Soap and fragrance-free.

Recommended Usage: Twice Daily AM/PM

Key Ingredients: Salicylic Acid, Mandelic Acid, Polyhydroxy Acids, Tea Tree Oil.

Contains: Two 7.2 fl oz bottles

Apply to wet skin and gently massage to develop foaming action. Rinse thoroughly with water. Use twice daily.
Aqua (Water), PEG-80 Sorbitan Laurate, Glycerin, Gluconolactone, Ammonium Laureth Sulfate, Triethanolamine, Disodium Cocoamphodiacetate, Mandelic Acid, Salicylic Acid, Panthenol (Pro-Vitamin B5), Melaleuca Alternifolia (Tea Tree) Leaf Oil, Sodium Laureth Sulfate, Sodium Laureth-13 Carboxylate, PEG-150 Distearate, Cocamidopropyl Betaine, Sodium Chloride, PEG-150 Pentaerythrityl Tetrastearate, PPG-2 Hydroxyethyl Cocamide, Polyquaternium-10, PEG-40 Hydrogenated Castor Oil, Polysorbate 20, BHT, Benzalkonium Chloride, Phenoxyethanol, Chlorphenesin.

#exuviance

Make a video, snap some selfies, and tell us how much you love it!

Customer Reviews

Reviews

Q&A